Floatz logo

PRAZOSIN

Post-Traumatic Headache

Seattle Institute for Biomedical and Clinical ResearchSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Post-Traumatic Headache cohort.

Same molecule, other indications

PRAZOSIN is also rated in:

Gastrointestinal HemorrhageDormant
BB
Indicative ·
69 / 100
View asset →
portal hypertensionDormant
BB
Indicative ·
65 / 100
View asset →
dementiaDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →